I. Haas
Impact in
- Otorhinolaryngology top 2%
- Head and Neck Cancer Studies
- Oncology top 10%
- Cancer Diagnosis and Treatment
- HER2/EGFR in Cancer Research
Papers in
- Oncology 8
- Cancer Cells and Metastasis 4
- HER2/EGFR in Cancer Research 2
-
- RNA Interference and Gene Delivery 2
- Co-authors
- U. Ganzer (9 shared papers)Thomas K. Hoffmann (3 shared papers)H. Bier (5 shared papers)U. Häuser (2 shared papers)Rainer Engers (1 shared paper)Anke Van Lierop (1 shared paper)D. Häfner (1 shared paper)P. Stasiecki (1 shared paper)
- Journals
- European Archives of Oto-Rhino-Laryngology (6 papers)ORL (1 paper)Journal of Chromatography A (1 paper)Cancer Immunology Immunotherapy (1 paper)Laryngo-Rhino-Otologie (2 papers)
- Partner nations
- GermanyUnited StatesSlovakia
In The Last Decade
I. Haas
15 papers receiving 417 citations
Peers
Comparison fields: 5 of 50
- Otorhinolaryngology 209
- Oncology 203
- Oral Surgery 20
- Pulmonary and Respiratory Medicine 75
- Radiology, Nuclear Medicine and Imaging 52
Countries citing papers authored by I. Haas
This map shows the geographic impact of I. Haas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Haas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Haas more than expected).
Fields of papers citing papers by I. Haas
This network shows the impact of papers produced by I. Haas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Haas. The network helps show where I. Haas may publish in the future.
Co-authors
The 15 scholars most cited alongside I. Haas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 128 | |
| 2 | 2001 | 81 | |
| 3 | 1998 | 78 | |
| 4 | Antitumor activity of anti-epidermal growth factor receptor monoclonal antibodies and cisplatin in ten human head and neck squamous cell carcinoma lines. | 1998 | 61 |
| 5 | 2002 | 32 | |
| 6 | 1995 | 25 | |
| 7 | 2003 | 7 | |
| 8 | 1987 | 5 | |
| 9 | 1995 | 4 | |
| 10 | 2002 | 3 | |
| 11 | 2000 | 3 | |
| 12 | 1998 | 2 | |
| 13 | 1999 | 1 | |
| 14 | 1996 | 1 | |
| 15 | 1996 | 1 | |
| 16 | 2010 | 0 | |
| 17 | 2010 | 0 |
About I. Haas
I. Haas is a scholar working on Oncology, Molecular Biology, Surgery, Otorhinolaryngology and Radiology, Nuclear Medicine and Imaging, having authored 17 papers that have together received 432 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Head and Neck Cancer Studies (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), RNA Interference and Gene Delivery (2 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Treatments and Mutations (2 papers), Cancer Genomics and Diagnostics (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Otorhinolaryngology (209 citations), Oncology (203 citations), Oral Surgery (20 citations), Pulmonary and Respiratory Medicine (75 citations) and Radiology, Nuclear Medicine and Imaging (52 citations). I. Haas has collaborated with scholars based in Germany, United States and Slovakia. Frequent co-authors include U. Ganzer, Thomas K. Hoffmann, H. Bier, U. Häuser, Rainer Engers, Anke Van Lierop, D. Häfner, P. Stasiecki, K. -A. Reiffen and P. Koldovský. Their work appears in journals such as European Archives of Oto-Rhino-Laryngology, ORL, Journal of Chromatography A, Cancer Immunology Immunotherapy and Laryngo-Rhino-Otologie.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.